Explore our core high-demand biological intermediates and cholic acid derivatives synthesized to global standards.
The global pharmaceutical supply chain is undergoing structural decentralization. For Chisinau, the capital of Moldova and a crucial logistics corridor bordering the European Union, this shift offers a unique chance to strengthen its domestic drug manufacturing and bio-chemical R&D sectors. A key element of this clinical advancement is the steady supply of high-purity cholic acid series products. These compounds serve as vital precursors for therapeutic formulations, diagnostic reagents, and innovative drug delivery matrices.
Bile acids, primarily cholic acid (CA) and its derivatives such as chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA), and taurine-conjugated variants (e.g., TUDCA), are no longer viewed merely as biological detergents. They are recognized as potent metabolic signaling molecules. By binding to nuclear receptors like the Farnesoid X Receptor (FXR) and G-protein coupled receptors such as TGR5, they influence hepatic, metabolic, and immunological pathways. Consequently, sourcing reliable, highly purified cholic acid derivatives is critical for pharmaceutical companies in Chisinau aiming to meet both European Medicines Agency (EMA) and local standards.
Moldova's pharmaceutical sector is modernizing, fueled by investments in GMP-certified facilities and a regulatory alignment with EU directives. Chisinau is at the center of this growth. Local manufacturers and research institutes are expanding beyond simple formulation steps to develop complex, high-value generic medicines and diagnostic assay kits.
This industrial transition requires advanced raw materials. Cholic acid derivatives are essential for production. For instance, UDCA is widely used to treat cholestatic liver diseases and dissolve cholesterol gallstones, making it a key component in regional gastroenterology medicine portfolios. Additionally, the rise of domestic diagnostic laboratories has increased the demand for raw cholesterol and bilirubin standards used to calibrate biochemical test kits.
The manufacturing process for our cholic acid series relies on advanced chemical synthesis and purification systems. While traditional methods extract cholic acid from bovine or porcine bile, our facilities utilize refined purification processes to prevent cross-contamination and guarantee batch consistency. Our technical roadmap focuses on reducing reliance on raw animal materials by exploring semi-synthetic pathways and enzymatic biotransformations.
By using specific bacterial enzymes to modify cholic acid, we can produce high-value derivatives like ursodeoxycholic acid (UDCA) and obeticholic acid with excellent chemical selectivity. This approach minimizes chemical waste, aligns with global green chemistry initiatives, and ensures that the final products comply with international regulatory standards.
The therapeutic utility of cholic acid derivatives spans several key areas. In gastroenterology, they are crucial for treating hepatic diseases. UDCA reduces the hydrophobic bile acid pool in circulation, protecting liver cells from injury and stabilizing cell membranes. Tauroursodeoxycholic acid (TUDCA) is also showing promise as a neuroprotective agent, being studied for its ability to reduce endoplasmic reticulum stress in neurodegenerative disease models.
In addition, bile acids are increasingly utilized in pharmaceutical nanotechnology. Because of their amphiphilic structure, cholic acid and its salts (such as sodium deoxycholate) can self-assemble into micelles in aqueous environments. These micellar structures act as advanced drug delivery systems, improving the solubility and absorption of poorly water-soluble medicines. This enables local drug developers in Chisinau to formulate high-performance treatments with enhanced bioavailability.
Chengdu ChenLv Herb Co.,Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
Integrating IoT architectures, DCS automatic controls, and end-to-end trace systems to secure your clinical development pipeline.
Our manufacturing complex represents the integration of industry-standard automation with chemical synthesis protocols. Our factory incorporates distributed control systems (DCS) that monitor and control critical process parameters (temperature, pH, solvent flow, and crystallization rates) in real-time. This level of process control ensures that every batch of cholic acid derivatives conforms to exact chemical specifications, reducing batch-to-batch variability.
By leveraging real-time data modeling and automated packaging lines, we minimize human intervention and eliminate potential pathways for external contamination. For companies in Chisinau, this high-throughput efficiency translates directly into predictable lead times, highly competitive bulk pricing, and reliable supply chains, even during periods of global logistics volatility.
Our facility utilizes green production metrics, recovering over 95% of processing solvents through automated rectification columns. This reduces manufacturing costs and lessens our environmental footprint, aligning with EU supply chain sustainability requirements.
From the raw bile or starting material to the finished powder stored in sealed drums, every step of our process is tracked via our ERP software. This guarantees that your quality assurance team can trace every batch back to its raw material origins.
Choose Chengdu Chenlv Herb for raw materials and chemical services that support your operations.
Creative molecular and formulation designs that enhance your active therapeutic research and brand positioning.
Optimized process pathways, fast turnarounds, and green packaging solutions aligned with modern international ecological standards.
End-to-end supply stability, ecological consciousness, and clean manufacturing protocols prioritizing green chemistry.
Dedicated technical support, regulatory assistance, and logistics solutions tailored to deliver products efficiently to Chisinau.
Rigorous in-house analytical testing using HPLC, MS, and GC systems to verify purity, heavy metal limits, and microbiology control.
Over a decade of biochemical engineering expertise, satisfying strict regulatory audits and client demands across the EU and globally.
Discover how our high-purity extracts and cholic acid derivatives serve diverse international sectors.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have gradually become the core raw materials for the development of health care products due to their natural, green and safe characteristics.
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts occupy the prominent position in the pharmaceutical industry due to their natural active ingredients and unique pharmacological effects.
With consumers' pursuit of natural, safe, and sustainable skincare concepts, plant extracts have become a new favorite in the cosmetics industry due to their mildness, versatility, and biocompatibility, bringing new solutions for skin care.
Chenlv Herb provides one-stop contract manufacturing and optimization services.
Communicate to determine raw material requirements.
Provide a detailed proposal quotation based on needs.
Sign agreement and establish quality benchmarks.
Prepare laboratory scale samples for initial validation.
Schedule order within our high-capacity GMP units.
Perform quality controls and issue the Certificate of Analysis (COA).
Deliver finished goods safely to Chisinau logistics points.
Our company is certified by ISO9001, ISO22000, HALAL, KOSHER and FDA, ensuring global regulatory compliance.






When selecting a biochemical exporter for Chisinau’s pharmaceutical sector, quality assurance and regulatory compliance are critical. The chemical profile of bile acids must be thoroughly evaluated before approval. Key considerations for sourcing include:
Importing chemical precursors into Moldova requires clear logistics coordination. As an experienced exporter, we handle customs clearance and documentation requirements for Chisinau's import authorities. We coordinate with air cargo hubs (like Chisinau International Airport - KIV) and overland logistics paths to manage temperature controls and storage conditions throughout transit. This preserves the chemical integrity and stability of the product from our warehouse to your facility.
Technical and logistical insights for cholic acid procurement and distribution in Chisinau.
Our pharmaceutical and reagent-grade cholic acid series products, including Cholic Acid, Chenodeoxycholic Acid, and Ursodeoxycholic Acid, maintain a standard purity of ≥98% to ≥99% by HPLC. Detailed Batch Certificates of Analysis (COAs) are provided with every shipment.
Yes, we provide full regulatory support. This includes helping with facility audits, supplying Drug Master Files (DMFs), and offering technical documentation to ensure compliance with the European Medicines Agency (EMA) and local Moldovan regulatory bodies.
For standard items, order processing and shipment take 7–10 working days. Depending on the shipping method selected (air freight or overland multimodal transport), transit times to Chisinau range from 5 to 15 days.
We source starting materials only from verified, certified slaughterhouses. We also run testing programs and hold official BSE/TSE-free certificates, ensuring our products are safe for pharmaceutical development.
Stay updated with the latest biochemical market insights and company events.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end, supply-demand dynamics are key.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery.
The 92nd China International Pharmaceutical Raw Materials / Intermediates / Packaging / Equipment Fair (API China) will grandly open at the China Import and Export Fair Exhibition Hall in Guangzhou.
Find our complete range of certified bile salts, acid derivatives, and manufacturing options.